These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29309830)

  • 21. Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.
    Kilinc M; Creson T; Rojas C; Aceti M; Ellegood J; Vaissiere T; Lerch JP; Rumbaugh G
    Mol Cell Neurosci; 2018 Sep; 91():140-150. PubMed ID: 29580901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders.
    Goodwin LR; Picketts DJ
    Mol Cell Neurosci; 2018 Mar; 87():55-64. PubMed ID: 29249292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for dissecting the complexity of neurodevelopmental disorders.
    Sun J; Noss S; Banerjee D; Das M; Girirajan S
    Trends Genet; 2024 Feb; 40(2):187-202. PubMed ID: 37949722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical versus automated assessments of morphological variants in twins with and without neurodevelopmental disorders.
    Myers L; Anderlid BM; Nordgren A; Lundin K; Kuja-Halkola R; Tammimies K; Bölte S
    Am J Med Genet A; 2020 May; 182(5):1177-1189. PubMed ID: 32162839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing motor development and function in mouse models of neurodevelopmental disorders.
    Dierdorff L; Garcia-Forn M; von Mueffling A; De Rubeis S
    Methods Cell Biol; 2024; 188():171-181. PubMed ID: 38880523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep EEG oscillations in neurodevelopmental disorders without intellectual disabilities.
    Gorgoni M; Scarpelli S; Reda F; De Gennaro L
    Sleep Med Rev; 2020 Feb; 49():101224. PubMed ID: 31731102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maltreatment-associated neurodevelopmental disorders: a co-twin control analysis.
    Dinkler L; Lundström S; Gajwani R; Lichtenstein P; Gillberg C; Minnis H
    J Child Psychol Psychiatry; 2017 Jun; 58(6):691-701. PubMed ID: 28094432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential genetic findings in neurodevelopmental disorders.
    Cardoso AR; Lopes-Marques M; Silva RM; Serrano C; Amorim A; Prata MJ; Azevedo L
    Hum Genomics; 2019 Jul; 13(1):31. PubMed ID: 31288856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of the Maternal and Child Health Handbook in Early Identification of Autism Spectrum Disorder and Other Neurodevelopmental Disorders.
    Hirota T; Bishop S; Adachi M; Shui A; Takahashi M; Mori H; Nakamura K
    Autism Res; 2021 Mar; 14(3):551-559. PubMed ID: 33251760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vestibular Function in Children with Neurodevelopmental Disorders: A Systematic Review.
    Van Hecke R; Danneels M; Dhooge I; Van Waelvelde H; Wiersema JR; Deconinck FJA; Maes L
    J Autism Dev Disord; 2019 Aug; 49(8):3328-3350. PubMed ID: 31102194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamics of chromatin architecture in brain development and function.
    Harabula I; Pombo A
    Curr Opin Genet Dev; 2021 Apr; 67():84-93. PubMed ID: 33421764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New gene discoveries highlight functional convergence in autism and related neurodevelopmental disorders.
    Moyses-Oliveira M; Yadav R; Erdin S; Talkowski ME
    Curr Opin Genet Dev; 2020 Dec; 65():195-206. PubMed ID: 32846283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic Formation, Neural Circuits and Neurodevelopmental Disorders Controlled by Signaling, Translation, and Epigenetic Regulation.
    Hsueh YP
    Dev Neurobiol; 2019 Jan; 79(1):2-7. PubMed ID: 30672130
    [No Abstract]   [Full Text] [Related]  

  • 34. Proliferation and Differentiation Deficits are a Major Convergence Point for Neurodevelopmental Disorders.
    Ernst C
    Trends Neurosci; 2016 May; 39(5):290-299. PubMed ID: 27032601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders.
    Song W; Li Q; Wang T; Li Y; Fan T; Zhang J; Wang Q; Pan J; Dong Q; Sun ZS; Wang Y
    Brain Behav Immun; 2022 May; 102():237-250. PubMed ID: 35245678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of GABAergic signalling in neurodevelopmental disorders.
    Tang X; Jaenisch R; Sur M
    Nat Rev Neurosci; 2021 May; 22(5):290-307. PubMed ID: 33772226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.
    Taoufik E; Kouroupi G; Zygogianni O; Matsas R
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research.
    Robinson JE; Gradinaru V
    Curr Opin Neurobiol; 2018 Feb; 48():17-29. PubMed ID: 28850815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population prevalence and inheritance pattern of recurrent CNVs associated with neurodevelopmental disorders in 12,252 newborns and their parents.
    Smajlagić D; Lavrichenko K; Berland S; Helgeland Ø; Knudsen GP; Vaudel M; Haavik J; Knappskog PM; Njølstad PR; Houge G; Johansson S
    Eur J Hum Genet; 2021 Jan; 29(1):205-215. PubMed ID: 32778765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and metabolic investigations for individuals with neurodevelopmental disorders: A survey of Canadian geneticists' practices.
    Carter MT; Cloutier M; Tsampalieros A; Webster R
    Am J Med Genet A; 2021 Jun; 185(6):1757-1766. PubMed ID: 33720531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.